Skip to content

Cigna CI Cash ratio

Cash ratio at other companies

Humana logo
HumanaHUM
0.2×0.0×
CVS Health logo
CVS HealthCVS
0.1×0.0×
UnitedHealth Group logo
UnitedHealth GroupUNH
0.2×0.0×
Elevance Health logo
Elevance HealthELV
0.2×0.0×
Cencora logo
CencoraCOR
0.0×
Centene logo
CenteneCNC
0.5×+0.1×

Other financials

Income statement

See full
Revenue$68.5B+4.6%
Gross profit$14.4B-15.8%
Operating income$2.4B+19.6%
Net income$1.7B+25.0%
EPS (diluted)$6.26+29.1%

Balance sheet

See full
Cash & equivalents$7.0B-15.5%
Total equity$42.2B+4.9%
Total assets$153.27B+1.7%

Cash flow

See full
Operating cash flow$1.1B-41.1%

Valuation

See full
Market cap$73.88B-21.1%
P/E11.9×-6.9×
P/S0.3×-0.1×

Profitability

See full
Gross margin20.6%-5.2pp
Operating margin3.4%-0.1pp
Net margin2.2%+0.3pp

Returns & leverage

See full
Return on equity15%+2.8pp
Debt / equity0.0×
Current ratio0.8×0.0×

Where this comes from

Calculated from Cigna’s reported figures.

Based on the most recent quarter.

The official record: Cigna’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cigna's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cigna's cash ratio?
Cigna (CI) reported cash ratio of 0.1× in Q1 2026.
How has Cigna's cash ratio changed year-over-year?
Cigna's cash ratio decreased by 10.5% year-over-year, from 0.1× to 0.1×.
What is the long-term trend for Cigna's cash ratio?
Over 4 years (2021 to 2025), Cigna's cash ratio has grown at a -2.4% compound annual growth rate (CAGR), from 0.5× to 0.5×.
What does cash ratio mean?
How much of its short-term bills the company could pay with cash on hand right now.
How do you interpret cash ratio?
A buffer against stress, but persistently high cash ratios can indicate under-deployed capital. Interpret alongside the company's capital-allocation strategy.
How does cash ratio compare across companies?
Varies widely by business model and treasury policy; best read against the company's own history.